|
|
 |
|
|
7th Conference of the Specialized Neuroscience Research Programs
New York, New York
|
Hosted by:
Hunter College of the City University of New York
Fiscal Agent: Research Foundation of The City University of New York
|
|
ABSTRACT SUBMISSION
DEADLINE FOR POSTER AND ORAL ABSTRACT SUBMISSION:
JUNE 13, 2008 |
It is strongly suggested that you review the information that is required for abstract submission well in advance of the deadline of JUNE 13, 2008. This will ensure that you have the very specific format and information required to submit the poster abstract.
GENERAL FORMAT GUIDELINES FOR POSTER AND ORAL ABSTRACT SUBMISSION
ABSTRACT FORMAT
Text may be copied into the text boxes by 'cut and paste'.
Abstract title:
- Maximum size 100 characters.
List authors in the following format:
- First initial, last Name
- Use footnote format for Department, Institute, Affiliation, City, State
- Underline primary author
Footnotes:
- List footnotes for authors
- Department, Institution/Organization, City, State. List country if other than United States
Summary of Research [Abstract Only].
- Maximum size approximately 2,500 characters, not counting spaces.
- Block left
- Use standard abbreviations. When using abbreviations for chemical compounds, spell out in full the first mention, followed by the abbreviation in parentheses. Do not abbreviate compounds in the title of the abstract
- Space, [list supporting agencies and details]
SAMPLE ABSTRACT SUBMISSION
Effects of Desipramine and Fluoxetine on Repetitive Nesting Behavior in Mus musculus
K.A. Alexander1, D.M. Greene1, D.K. Raap2, and A. Bult-Ito1
1Alaskan Basic Neuroscience Program, Institute of Arctic Biology, 2Department of Psychology, University of Alaska Fairbanks, Fairbanks, AK.
Unlike Selective serotonin re-uptake inhibitors (SSRIs) such as fluoxetine and the tricyclic antidepressant clomipramine, desipramine (another tricyclic antidepressant) is not effective in treating obsessive compulsive disorder (OCD) in humans. This study examined the effects of fluoxetine and desipramine on compulsive-like excessive nest-building behavior in mice (Mus musculus) to examine the appropriateness of these mice as an animal model of OCD. If these mice are a good animal model of compulsive disorders, then they should respond to drug treatment similarly to human OCD patients, showing a decrease in repetitive nesting behaviors with fluoxetine and no decrease with desipramine. To examine this, the amount of cotton used for nest building in 49 mice bred for excessive nest-building behavior was recorded for 3 weeks prior to drug treatment, 4 weeks during, and 4 weeks after oral administration of either desipramine, fluoxetine, or vehicle (30mg/kg/day desipramine, 50mg/kg/day fluoxetine, sucrose vehicle). We found that the fluoxetine-treated mice significantly decreased cotton usage and the desipramine treated mice had no significant differences in cotton usage from the control group. These data support the hypothesis that the excessive nesting behaviors in these mice may be similar to the compulsive behaviors seen in humans suffering from OCD. These findings further support the hypothesis that these mice are a valuable animal model of compulsive disorders such as OCD, and may prove to be useful for understanding the neurobiological and neurochemical basis of compulsive disorders.
[Supported by NIH grants 1R15MH58453 (NIMH) and 1U54NS41069 (SNRP: NINDS, NIMH, NCRR, NCMHD)]
POSTER ABSTRACT SUBMISSION
The SNRP highlights the range and quality of neuroscience research conducted at minority institutions. On Thursday, August 21 as part of this SNRP Conference program there will be a poster viewing followed by poster presentations during which time there will be ballot voting of the eligible posters for the Haxhiu-N.E.U.R.O.N. Award. For eligibility and information on the Haxhiu-N.E.U.R.O.N. Travel Award, refer to the Haxhiu-N.E.U.R.O.N. Travel Award tab link.
Poster Abstracts are being accepted online only. All poster presenters must have submitted an abstract prior to the submission deadline. The deadline to submit abstracts is June 13, 2008. There is no fee for submitting an abstract.
INSTRUCTIONS FOR SUBMISSION OF POSTER ABSTRACTS
Please read the following information carefully. Abstracts and Posters that do not adhere to all of these criteria may be rejected or withdrawn. Please note that only abstracts with scientific or educational merit will be accepted.
- Any conference registrant may submit an abstract for poster presentation.
- A registrant may only submit one abstract to present one poster.
- The registrant who submits the abstract is responsible for ensuring that work presented in the abstract conforms with the applicable policy and principles for experimental procedures. (ie SFN's policies on using animals and human subjects in neuroscience research)
- To ensure proper citation in the author index, style your name consistently and list the same contact email address on all abstracts on which you are an author.
- The abstract should state the study's objective, briefly describe the methods used, summarize the results obtained, and state the conclusions. It is not satisfactory to say, "The results will be discussed." Abstracts should emphasize the significance of results and general principles rather than ordinary methods and procedures. When experimental animals are used, the species should be stated. When relevant, the sex of experimental animals and humans should be noted. Use standard abbreviations for units of measure. Other abbreviations should be fully spelled out on first mention, followed by the abbreviation in parentheses.
- Authors should disclose their sources of contributed support (commercial, public, or private foundation grants). This information will emphasize the importance of the organizations that sponsor research. Enter the source(s) in the appropriate field during submission (not in the abstract body).
- Any need for conflict of interest or disclosure information?
- Material presented at the meeting must be substantively identical to that described in the abstract. In particular, the title, authorship, and scientific content of the presentation at the meeting must match that in the abstract.
- Live exhibits cannot be accommodated at the meeting.
POSTER INFORMATION
- Posters are to be set up in the 2nd floor Financial Ballroom after 7:45pm on Tuesday, August 19.
- Poster boards are standard 4 feet x 8 feet boards.
- Posters must be removed at the end of the conference. Any posters left on boards after the conference ends will be discarded.
- Poster presenters are responsible for poster set up, display, removal, and shipping of materials.
- Conference planners are not responsible for poster handling.
- Push Pins for poster set up will be provided.
- An individual may appear as the first (presenting) author on only one abstract. The first author should present the work at the meeting. No presentation may be given by an individual who is not an author on the abstract. An author must be present with the poster at all times during the poster viewing and presentation time.
- Top six eligible poster presenters will present a ten minute power point presentation on Friday, August 22.
|
|
|
|
|
|
|
